November 27, 2024
Michael Crotty, MD, provides practical guidance for on integrating GLP-1 receptor agonists into a comprehensive obesity treatment plan.
November 27, 2024
Obesity medicine specialist Michael Crotty, MD, discusses the benefits of GLP-1 receptor agonist use in weight management and its impact on obesity-related comorbidities.
November 27, 2024
Your daily dose of the clinical news you may have missed.
November 26, 2024
The investigational weight loss drug showed substantial weight loss among people with obesity or overweight with or without T2D without plateaus.
November 26, 2024
Comments on the draft recommendation can be submitted through December 23, 2024.
November 26, 2024
Your daily dose of the clinical news you may have missed.
November 25, 2024
Your daily dose of the clinical news you may have missed.
November 25, 2024
William Grady, MD, coauthor of the ECLIPSE trial, discusses how the Shield cfDNA blood-based test compares to traditional CRC screening methods.
November 22, 2024
William Grady, MD, highlights the convenience and compliance of blood-based tests compared to colonoscopy and stool-based tests for colorectal cancer screening.
November 22, 2024
Your daily dose of the clinical news you may have missed.